1. Paroni M, Maltese V, De Simone M, Ranzani V, Larghi P, Fenoglio C, et al. Recognition of viral and self-antigens by T H 1 and T H 1/T H 17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses. J Allergy Clin Immunol. 2017; 140(3): 797-808. [DOI:10.1016/j.jaci.2016.11.045]

2. Martin R, Sospedra M, Rosito M, Engelhardt B. Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis. Eur J Immunol. 2016; 46(9): 2078-90. [DOI:10.1002/eji.201646485]

3. Cheng Y, Sun L, Xie Z, Fan X, Cao Q, Han J, et al. Diversity of immune cell types in multiple sclerosis and its animal model: Pathological and therapeutic implications. J Neurosci Res. 2017; 95(10): 1973-83. [DOI:10.1002/jnr.24023]

4. Mentis A-FA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and multiple sclerosis: from mechanisms and pathways to translational research opportunities. Mol Neurobiol. 2017; 5(54): 3911-23. [DOI:10.1007/s12035-017-0530-6]

5. Taherkhani R, Farshadpour F, Mirjalili A, Amirinejad R. Determination of the association between Epstein-Barr virus (EBV) infection and Multiple sclerosis (MS) disease. Iranian South Medical Journal. 2014; 17(4): 666-75.

6. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006; 19(1): 80-94. [DOI:10.1128/CMR.19.1.80-94.2006]

7. Hon GM, Hassan MS, van Rensburg SJ, Erasmus RT, Matsha TE. Assessment of epstein-barr virus in blood from patients with multiple sclerosis. Metab Brain Dis. 2012; 27(3): 311-8. [DOI:10.1007/s11011-012-9292-z]

8. Pormohammad A, Azimi T, Falah F, Faghihloo E. Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta‐analysis. J Cell Physiol. 2017. doi: 10.1002/jcp.26000. [DOI:10.1002/jcp.26000]

9. Khaki M, Ghazaavi A, Ghasami K, Rafiei M, Payani M, Mosayebi G. Anti-human herpes virus-6 antibodies titer in patients with multiple sclerosis in Markazy Province. Arak Medical University Journal. 2009; 12(2): 45-50.

10. Levy JA. Three new human herpesviruses (HHV6, 7, and 8). Lancet. 1997; 349(9051): 558-63. [DOI:10.1016/S0140-6736(97)80119-5]

11. Ablashi D, Eastman H, Owen C, Roman M, Friedman J, Zabriskie J, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16(3): 179-91. [DOI:10.1016/S1386-6532(99)00079-7]

12. Mehta SK, Nelman‐Gonzalez M, Tyring SK, Tong Y, Beitman A, Crucian BE, et al. Localization of VZV in saliva of zoster patients. J Med Virol. 2017; 89(9): 1686-9. [DOI:10.1002/jmv.24807]

13. Karampoor S, Zahednasab H, Ramagopalan S, Mehrpour M, Etemadifar M, Alsahebfosoul F, et al. Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients with multiple sclerosis: a population-based study. J Neuroimmunol. 2017; 309: 4-6. [DOI:10.1016/j.jneuroim.2017.04.004]

14. Gordon L, McQuaid S, Cosby S. Detection of herpes simplex virus (types 1 and 2) and human herpesvirus 6 DNA in human brain tissue by polymerase chain reaction. Clin Diagn Virol. 1996; 6(1): 33-40. [DOI:10.1016/0928-0197(95)00203-0]

15. Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L, et al. Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein in patients with multiple sclerosis. Ann Neurol. 2001; 50(4): 486-93. [DOI:10.1002/ana.1135]

16. Berti R, Brennan MB, Soldan SS, Ohayon JM, Casareto L, McFarland HF, et al. Increased detection of serum HHV-6 DNA sequences during Multiple Sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol. 2002; 8(3): 250-6. [DOI:10.1080/13550280290049615-1]

17. Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis. 2000; 182(5): 1321-5. [DOI:10.1086/315893]

18. Pawate S, Sriram S. The role of infections in the pathogenesis and course of multiple sclerosis. Ann Indian Acad Neurol. 2010; 13(2): 80-6. [DOI:10.4103/0972-2327.64622]

19. Ben Fredj N, Rotola A, Nefzi F, Chebel S, Rizzo R, Caselli E, et al. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol. 2012; 18(1): 12-9. [DOI:10.1007/s13365-011-0056-z]

20. Enbom M, Wang FZ, Fredrikson S, Martin C, Dahl H, Linde A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol. 1999; 6(4): 545-9.

21. Najafi S, Ghane M, Yousefzadeh-Chabok S, Amiri M. The high prevalence of the varicella zoster virus in patients with relapsing-remitting multiple sclerosis: a case-control study in the north of Iran. Jundishapur J Microbiol. 2016; 9(3). doi: 10.5812/jjm. 34158. [DOI:10.5812/jjm]

22. Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, et al. An altered immune response to epstein-barr virus in multiple sclerosis a prospective study. Neurology. 2004; 62(12): 2277-82. [DOI:10.1212/01.WNL.0000130496.51156.D7]